These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35393710)

  • 1. COVID-19 and autoimmune phenomena: Vitiligo after Astrazeneca vaccine.
    López Riquelme I; Fernández Ballesteros MD; Serrano Ordoñez A; Godoy Díaz DJ
    Dermatol Ther; 2022 Jul; 35(7):e15502. PubMed ID: 35393710
    [No Abstract]   [Full Text] [Related]  

  • 2. Newly-developed vitiligo following COVID-19 mRNA vaccine.
    Uğurer E; Sivaz O; Kıvanç Altunay İ
    J Cosmet Dermatol; 2022 Apr; 21(4):1350-1351. PubMed ID: 35152540
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to "COVID vaccine-induced lichen planus on areas previously affected by vitiligo".
    Bularca E; Monte-Serrano J; Villagrasa-Boli P; Lapeña-Casado A; de-la-Fuente S
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e423-e425. PubMed ID: 35148438
    [No Abstract]   [Full Text] [Related]  

  • 4. A new-onset vitiligo following the inactivated COVID-19 vaccine.
    Koç Yıldırım S
    J Cosmet Dermatol; 2022 Feb; 21(2):429-430. PubMed ID: 34910371
    [No Abstract]   [Full Text] [Related]  

  • 5. Vitiligo following the COVID-19 Vaccination and Infection.
    Green M; Feschuk A; Kashetsky N; Maibach HI
    Skinmed; 2023; 21(3):213-216. PubMed ID: 37634112
    [No Abstract]   [Full Text] [Related]  

  • 6. Sudden onset of vitiligo after COVID-19 vaccine.
    Ciccarese G; Drago F; Boldrin S; Pattaro M; Parodi A
    Dermatol Ther; 2022 Jan; 35(1):e15196. PubMed ID: 34751491
    [No Abstract]   [Full Text] [Related]  

  • 7. [Facial Vitiligo After SARS-CoV-2 Vaccination].
    Flores-Terry MÁ; García-Arpa M; Santiago-Sánchez Mateo JL; Romero Aguilera G
    Actas Dermosifiliogr; 2022; 113(7):721. PubMed ID: 35221340
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiotherapy-induced vitiligo: A systematic review of patient demographics and clinical characteristics of vitiligo following radiation therapy.
    Mansour MR; Abushukur Y; Rehman RA; Shah C; Mehregan D
    J Am Acad Dermatol; 2022 Dec; 87(6):1445-1448. PubMed ID: 35995610
    [No Abstract]   [Full Text] [Related]  

  • 9. Vitiligo in underrepresented communities: An All of Us database analysis.
    Ahmed F; Moseley I; Ragi SD; Ouellette S; Rao B
    J Am Acad Dermatol; 2023 Apr; 88(4):945-948. PubMed ID: 36414097
    [No Abstract]   [Full Text] [Related]  

  • 10. Case report of acute encephalitis following the AstraZeneca COVID-19 vaccine.
    Li SY; Chen HH; Liu PY; Shi ZY; Lin YH; Tsai CA; Lin SP
    Int J Rheum Dis; 2022 Aug; 25(8):950-956. PubMed ID: 35748025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitiligo and systemic lupus erythematosus: A population-based study investigating the epidemiological association.
    Kridin K; Abou Amara Y; Barhoum M; Cohen AD
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2262-2263. PubMed ID: 37326169
    [No Abstract]   [Full Text] [Related]  

  • 12. Lichen planus and vitiligo occurring after ChAdOx1 nCoV-19 vaccination against SARS-CoV-2.
    Gamonal SBL; Gamonal ACC; Marques NCV; Adário CL
    Dermatol Ther; 2022 May; 35(5):e15422. PubMed ID: 35254713
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between the CTLA4 +49A/G (rs231775) and CT60 (rs3087243) gene variants with vitiligo: study on a Mexican population.
    Salinas-Santander MA; Suárez-Valencia VJ; Ángel-Martínez MD; Kubelis-Lopez DE; Zapata-Salazar NA; Ocampo-Garza JA; Ocampo-Candiani J
    An Bras Dermatol; 2022; 97(6):710-715. PubMed ID: 36163113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitiligo and melanoma-associated hypopigmentation (MAH): shared and discriminative features.
    Hartmann A; Bedenk C; Keikavoussi P; Becker JC; Hamm H; Bröcker EB
    J Dtsch Dermatol Ges; 2008 Dec; 6(12):1053-9. PubMed ID: 18479500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Worsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID-19 vaccine.
    Okan G; Vural P
    Dermatol Ther; 2022 Mar; 35(3):e15280. PubMed ID: 34931408
    [No Abstract]   [Full Text] [Related]  

  • 16. New-onset vitiligo after COVID-19 mRNA vaccination: A causal association?
    Nicolaidou E; Vavouli C; Koumprentziotis IA; Gerochristou M; Stratigos A
    J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):e11-e12. PubMed ID: 35971993
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment recommendations for patients with vitiligo during COVID-19.
    Rodrigues M; Pandya AG; Hamzavi I; Ezzedine K; Bekkenk MW; Harris JE
    Australas J Dermatol; 2021 Aug; 62(3):e481-e482. PubMed ID: 34028796
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of experimental autoimmune vitiligo by oral administration of mushroom tyrosinase.
    Zehtab T; Yazdanparast R; Rafieii S
    Cytobios; 2001; 105(408):27-34. PubMed ID: 11368265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of COVID-19 related complications in vitiligo patients: A database study.
    Raiker R; Pakhchanian H; Salingaros S; Helm M
    J Dtsch Dermatol Ges; 2022 Nov; 20(11):1505-1508. PubMed ID: 36210055
    [No Abstract]   [Full Text] [Related]  

  • 20. Melanoma-associated hypopigmentation: where are the antibodies?
    Merimsky O; Shoenfeld Y; Baharav E; Altomonte M; Chaitchik S; Maio M; Ferrone S; Fishman P
    Am J Clin Oncol; 1996 Dec; 19(6):613-8. PubMed ID: 8931683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.